Merck KGaA
XETRA:MRK
Merck KGaA
XETRA:MRK
Price:
148.95 EUR
-0.67%
Market Closed
Updated:
May 1, 2024
Merck KGaA
Cash from Financing Activities
|
Merck KGaA
Cash from Financing Activities Peer Comparison
Comparables:
ATAI
BAYN
93M1
DMP
PSG
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Merck KGaA
XETRA:MRK
|
Cash from Financing Activities
-€1.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-5%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Cash from Financing Activities
-$8.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Cash from Financing Activities
-€679m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
12%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Cash from Financing Activities
-€3.2m
|
CAGR 3-Years
30%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Cash from Financing Activities
€204.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Cash from Financing Activities
-€12.1m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Merck KGaA's Cash from Financing Activities?
Cash from Financing Activities
-1.7B
EUR
-1.7B
EUR
Based on the financial report for Dec 31, 2023, Merck KGaA's Cash from Financing Activities amounts to -1.7B EUR.
What is Merck KGaA's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-5%
-5%
Over the last year, the Cash from Financing Activities growth was -11%. The average annual Cash from Financing Activities growth rates for Merck KGaA have been -4% over the past three years , 9% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
